Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "healthcare"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "healthcare."

12 result(s) displayed (85 - 96 of 104)


Unclear diagnosis

The $19 billion healthcare stimulus plan helps create a rising tide, but will it buoy technology companies? Continue reading

Posted on March 6, 2009 11:23 AM




The patient is doing well

PE activity in the Southwest, particularly in healthcare, holds its own. Continue reading

Posted on January 9, 2009 1:31 PM




Quality judgments

Assessments of hospital care improvements are increasingly critical in merger assessments and for healthcare reform. Continue reading

Posted on December 1, 2008 2:14 PM




This won't hurt a bit

An examination of U.S. healthcare under the Obama administration. Continue reading

Posted on November 14, 2008 3:15 PM




The Supreme question

Does the FDA trump the states? Continue reading

Posted on November 14, 2008 3:14 PM




Nathaniel Zilkha of KKR on healthcare reform

Nathaniel Zilkha of Kohlberg Kravis Roberts & Co. on the rising costs of managed care and healthcare reform. Continue reading

Posted on October 24, 2008 1:56 PM




Fiona Schaeffer, partner, Weil, Gotshal & Manges:

A partner at Weil, Gotshal & Manges, Fiona Schaeffer specializes in antitrust counseling, litigation and transactional matters. She is also a vice chair of the International Antitrust Committee of the ABA's Section of Antitrust Law; and a co-chair of the International Antitrust Committee of the ABA's Section of International Law. Continue reading

Posted on April 8, 2008 3:01 PM




David P. Wales, Deputy Director, FTC's Bureau of Competition

David P. Wales is Deputy Director of the Federal Trade Commission's Bureau of Competition. Prior to joining the FTC, he was a partner in the antitrust practice group of Cadwalader, Wickersham & Taft LLP, handling antitrust litigation, mergers and acquisitions, joint ventures, distribution arrangements, competitor collaborations and grand jury investigations. Continue reading

Posted on April 8, 2008 2:40 PM




Richard J. Zall, Partner, Proskauer Rose LLP:

Richard J. Zall is a partner at Proskauer Rose LLP and Chair of the firm's Health Industry practice group. His practice is focused on corporate and regulatory representation of health care clients, including academic medical centers, hospitals, and physician organizations; information technology and medical device companies; managed care and health benefit management companies; and private equity firms. Continue reading

Posted on April 7, 2008 2:56 PM




Chul Pak, Partner, Wilson Sonsini, Goodrich & Rosati:

Chul Pak is a partner at Wilson Sonsini, Goodrich & Rosati and a former assistant director of the Mergers IV Division at the Federal Trade Commission. In this clip Pak discussses the regulatory outlook for healthcare deals over the next year at The Healthcare Dealmaking Symposium. Continue reading

Posted on April 5, 2008 2:15 PM




Christine Arakelian, VP of Business Development at Omnicare

Prior to Omnicare, Christine Arakelian led corporate development positions at Neighborcare and Alpharma. She is a corporate and licensing attorney, with a J.D. from the University of Virginia and a B.A. with honors from the University of Pennsylvania. Continue reading

Posted on April 4, 2008 4:42 PM




Nathaniel Zilkha, a Principal at KKR

A Principal at KKR, Nathaniel Zilkha focuses on investments in healthcare. Prior to joining KKR, he led the healthcare investing efforts for the Goldman Sachs Capital Partners funds. Continue reading

Posted on April 4, 2008 2:34 PM




Previous 1 2 3 4 5 6 7 8 9 Next

Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Mayer Brown LLP hires Lawrence V. Berkovich as a partner in the banking and finance practice, amid "rapid growth of the CLO market." For other updates launch today's Movers & shakers slideshow.

Video

Goode Partners feasts on IPO returns

The firm's Daniel Bonoff discusses the difficult environment for finding quality targets, but welcomes a hot market for issuers. More video

Sectors